Omecap 40 mg Capsule is a proton pump inhibitor containing omeprazole, used for acid-related conditions. It is manufactured by Chemist Laboratories Ltd. and comes as a capsule.
There are 120 brands of Omeprazole listed in Bangladesh. 70 of them have a lower unit price than Omecap. The lowest listed price is Re 40 mg Capsule at ৳ 1 per unit.
What is Omecap 40 mg Capsule?
Omecap 40 mg Capsule contains omeprazole, a proton pump inhibitor that reduces stomach acid production. It is used for conditions such as gastric and duodenal ulcers, gastro-esophageal reflux disease, and acid-related dyspepsia. The medicine works by blocking the enzyme system in the stomach that produces acid. It is available as a 40 mg capsule. The doctor will decide the appropriate dose and duration of treatment based on your condition. Do not self-medicate; always follow the prescribed instructions.
Uses of Omecap
Omecap 40 mg Capsule is used to treat gastric and duodenal ulcers, including those associated with NSAID use. It is also used for gastro-esophageal reflux disease and its long-term management, acid-related dyspepsia, and severe ulcerating reflux esophagitis. Additionally, it can help prevent relapse in patients with a history of NSAID-associated ulcers. Your doctor will determine if this medicine is suitable for your specific condition.
How to use Omecap
Take Omecap 40 mg Capsule exactly as prescribed by your doctor. The dose and duration depend on your condition. Swallow the capsule whole with water; do not chew or crush it. You can take it with or without food, but consistency is important. Do not change the dose or stop treatment without consulting your doctor. If you miss a dose, take it as soon as you remember, unless it is almost time for the next dose. Do not double the dose.
Side effects of Omecap
Omecap 40 mg Capsule is generally well tolerated. Some people may experience mild and transient side effects such as nausea, abdominal colic, paresthesia, dizziness, and headache. These usually do not require a reduction in dosage. If any side effect persists or becomes bothersome, inform your doctor. Serious side effects are rare, but seek medical attention if you experience severe symptoms. Always consult your doctor for advice on managing side effects.
Safety and precautions
Before starting Omecap 40 mg Capsule, tell your doctor if you are allergic to omeprazole or any of its ingredients. If gastric ulcer is suspected, your doctor will first rule out gastric malignancy, as this medicine may relieve symptoms and delay diagnosis. The US FDA pregnancy category is C, but studies show no adverse effects on pregnancy or the fetus. There is no information on its passage into breast milk; breastfeeding should be discontinued if this medicine is essential. Always consult your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Frequently asked questions
What does the generic name omeprazole mean?
Omeprazole is the generic name of the active ingredient in Omecap 40 mg Capsule. It belongs to a class of medicines called proton pump inhibitors, which reduce stomach acid production. Generic names are standardised names used worldwide for the same active substance.
What is Omecap 40 mg Capsule used for and what kind of medicine is it?
Omecap 40 mg Capsule is a proton pump inhibitor used for acid-related conditions such as gastric and duodenal ulcers, gastro-esophageal reflux disease, and acid-related dyspepsia. It works by blocking the enzyme system in the stomach that produces acid, thereby reducing acid secretion.
Which medicines may interact with Omecap 40 mg Capsule?
Omeprazole can prolong the elimination of diazepam, warfarin, and phenytoin, so dose adjustments of warfarin or phenytoin may be needed when taken together. No interaction has been reported with theophylline, propranolol, or antacids. Always inform your doctor about all medicines you are taking.
As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
... Read more
Omeprazole is indicated for the treatment of-
Gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer
As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
Acid-related dyspepsia
Severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Zollinger-Ellison syndrome
Helicobacter pylori-induced peptic ulcer.
Pharmacology
Omeprazole, a substituted benzimidazole, is an inhibitor of gastric acid secretion. It inhibits gastric acid secretion by blocking hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system in the gastric parietal cell. After oral administration, the onset of the antisecretory effect occurs within one hour, with the maximum effect occurring within two hours and inhibition of secretion lasts up to 72 hours. When the drug is discontinued, secretory activity returns gradually, over 3 to 5 days.
Dosage & Administration
Oral-
Benign gastric and duodenal ulcer: 20 mg once daily for 4 weeks in duodenal ulceration, 8 weeks in gastric ulceration; in severe or recurrent cases, dose to be increased to 40 mg daily; maintenance dose for recurrent duodenal ulcer, 20 mg once daily; in prevention of relapse in duodenal ulcer, 10-20 mg daily.
NSAID-associated duodenal or gastric ulcer: 20 mg once daily for 4 weeks, continued for further 4 weeks, if not fully healed. 20 mg once daily is used as prophylaxis in patients with a history of NSAID-associated duodenal or gastric ulcers.
Gastro-esophageal reflux disease: 20 mg once daily for 4 weeks, continued for further 4-8 weeks, if not fully healed; 40 mg once daily has been given for 8 weeks in gastro-esophageal reflux disease, refractory to other treatment; maintenance dose is 20 mg once daily.
Long-term management of acid reflux disease: 10-20 mg daily.
Acid-related dyspepsia: 10-20 mg once daily for 2-4 weeks.
Prophylaxis of acid aspiration: 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery.
Zollinger-Ellison syndrome: Initially 60 mg once daily; usual range 20-120 mg daily (If daily dose is more than 80 mg, 2 divided dose should be used).
Helicobacter pylori eradication regimen in peptic ulcer disease: Omeprazole is recommended at a dose of 20 mg twice daily in association with antimicrobial agents as detailed below: Amoxicillin 500 mg and Metronidazole 400 mg both three times a day for one week, or Clarithromycin 250 mg and Metronidazole 400 mg both twice a day for one week, or Amoxicillin 1 g and Clarithromycin 500 mg both twice a day for one week.
Paeditaric use in severe ulcerating reflux esophagitis (Child>1 year): If body-weight 10-20 kg, 10-20 -mg once daily for 4-12 weeks; if body-weight over 20 kg, 20-40 mg once daily for 4-12 weeks.
IV Injection-
Prophylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.
Duodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.
Zollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.
Interaction
Omeprazole can prolong the elimination of diazepam, warfarin and phenytoin. So, reduction of warfarin or phenytoin dose may be necessary when Omeprazole is added to the treatment. There is no evidence of an interaction of Omeprazole with theophylline, propranolol or antacids.
Contraindications
Omeprazole is contraindicated in patients with known hypersensitivity to any of the components of the formulation.
Side Effects
Omeprazole is generally well tolerated. Nausea, abdominal colic, paresthesia, dizziness and headache have been stated to be generally mild and transient and not requiring a reduction in dosage.
Pregnancy & Lactation
US FDA pregnancy category of Omeprazole is C. However, results from three prospective epidemiological studies indicate no adverse effects of Omeprazole on pregnancy or on the health of the fetus/newborn child. There is no information available on the passage of Omeprazole into breast milk or its effects on the neonate. Breast-feeding should, therefore, be discontinued, if the use of Omeprazole is considered essential.
Precautions & Warnings
When gastric ulcer is suspected, the possibility of gastric malignancy should be excluded before treatment with Omeprazole is instituted, as treatment may alleviate the symptoms and delay diagnosis.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Alternative brands of Omeprazole
Other brands with the same generic name, cheapest first.